Cite

HARVARD Citation

    Karakaya, F. et al. (2017). Discontinuation of Lamivudine Treatment in HBeAg-Negative Chronic Hepatitis B: A Pilot Study with Long-Term follow-up. Antiviral therapy. 22 (7), pp. 559-570. [Online]. 
  
Back to record